Skip to content
Disclosery

13F-HR filed by Artia Global Partners LP

Artia Global Partners LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 55 holding rows worth $705,757,478.

Accession
0001937964-26-000002
Filer
CIK 1937964
Filed
2026-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2025

A holdings report, 55 entries on the cover page, a total value of $705,757,478 stated on the cover page (in dollars after the unit check, H1), rows summing to $705,757,478 with VALUE read as dollars as filed, 13F file number 028-23071. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INSMED INC COM PAR $.01457669307Stock682,212$118,732,177dollars as filed
ABIVAX SA-00370M103SPONSORED ADS600,747$81,013,737dollars as filed
INSMED INC COM PAR $.01457669307Stock420,000$73,096,800dollars as filedput
ARGENX SE SPONSORED ADR04016X101ADR64,699$54,408,624dollars as filed
Eli Lilly and Company532457108COM50,500$54,271,340dollars as filed
VIKING THERAPEUTICS INC92686J106COM719,365$25,307,261dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock2,013,602$25,210,297dollars as filed
SOLENO THERAPEUTICS INC834203309COM533,698$24,710,217dollars as filed
PROSHARES TR II74347W601ULTRA GOLD442,119$24,546,447dollars as filed
UNIQURE NVN90064101SHS1,023,539$24,493,288dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK503,936$17,678,075dollars as filed
ASTRAZENECA PLC SPONSORED ADR046353108ADR190,752$17,535,831dollars as filed
CIDARA THERAPEUTICS INC171757206COM NEW70,824$15,644,313dollars as filed
EYEPOINT INC COM NEW30233G209Stock767,098$14,014,880dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock144,376$11,421,585dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM205,090$8,451,759dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock104,190$8,298,734dollars as filed
QUEST DIAGNOSTICS INC COM74834L100Stock40,817$7,082,974dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock17,400$6,919,110dollars as filed
Ventyx Biosciences Inc92332V107Common Stock695,982$6,284,717dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK59,200$6,196,464dollars as filed
PROSHARES TR II74347W601ULTRA GOLD100,000$5,552,000dollars as filedput
MINERALYS THERAPEUTICS INC603170101COM137,800$5,000,762dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK119,741$4,926,145dollars as filed
PALISADE BIO INC696389402COMMON STOCK1,992,367$4,682,062dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock60,100$4,335,013dollars as filed
SCHOLAR ROCK HLDG CORP80706P103COM96,285$4,241,354dollars as filed
RAPPORT THERAPEUTICS INC COM75383L102Stock138,508$4,202,333dollars as filed
PROKIDNEY CORP74291D104CMN1,838,411$4,118,041dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR17,740$3,782,878dollars as filed
AbbVie,Inc.00287Y109COM14,500$3,313,105dollars as filed
BELITE BIO INC07782B104CMN17,989$2,877,520dollars as filed
ROIVANT SCIENCES LTDG76279101SHS129,800$2,816,660dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM70,700$2,701,447dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK33,407$2,607,082dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock5,000$2,436,250dollars as filed
SOLENO THERAPEUTICS INC834203309COM50,000$2,315,000dollars as filedcall
PROTAGONIST THERAPEUTICS74366E102COM22,951$2,004,540dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK68,653$1,863,929dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock40,000$1,792,800dollars as filed
OCULAR THERAPEUTIX INC67576A100COM141,061$1,712,481dollars as filed
BRIDGEBIO PHARMA INC10806X102COM20,400$1,560,396dollars as filed
BRIGHTSPRING HEALTH SVCS10950A106COM41,600$1,557,920dollars as filed
PEPGEN INC COM713317105Stock205,324$1,336,659dollars as filed
ABIVAX SA-00370M103SPONSORED ADS9,900$1,335,065dollars as filedcall
CELCUITY INC15102K100COM12,900$1,286,646dollars as filed
KINIKSA PHARMACEUTICALS INTL P ORD SHS CL AG52694109Stock29,200$1,204,500dollars as filed
OCULAR THERAPEUTIX INC67576A100COM85,200$1,034,328dollars as filedcall
NUVALENT INC COM670703107Stock8,100$814,779dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK41,570$754,911dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW2,500$736,850dollars as filed
ALTO NEUROSCIENCE INC COM SHS02157Q109Stock29,192$519,618dollars as filed
TENAX THERAPEUTICS INC88032L605COM NEW42,080$512,955dollars as filed
KODIAK SCIENCES INC50015M109COM17,019$475,851dollars as filed
LYRA THERAPEUTICS INC55234L204COM NEW8,756$26,968dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001937964-26-000002this filing2026-02-17acceptance time not in the bulk data set